Sign Up For Updates

Session 1: “Impact of Recent Clinical Trials on the Management of Neovascular AMD”

April 25, 2021

Learning Objectives

  • Describe how clinical trial results differentiate treatments based on functional, anatomic, and visual outcomes
  • Sequence and combine therapies appropriately based on response to anti-VEGF and other patient-specific factors


This activity is supported by an independent medical education grant from Alcon Vision, LLC, Novartis, Regeneron Pharmaceuticals, and RegenexBio.